Sound Income Strategies’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-788
Closed -$158K 635
2026
Q1
$158K Sell
788
-3
-0.4% -$578 0.01% 469
2025
Q4
$149K Buy
791
+278
+54% +$48.8K 0.01% 486
2025
Q3
$87.2K Buy
513
+77
+18% +$11.7K ﹤0.01% 430
2025
Q2
$60.9K Sell
436
-10
-2% -$1.4K ﹤0.01% 480
2025
Q1
$65.6K Sell
446
-39
-8% -$5.64K ﹤0.01% 454
2024
Q4
$63.6K Buy
485
+42
+9% +$5.88K ﹤0.01% 422
2024
Q3
$69K Sell
443
-63
-12% -$10.2K ﹤0.01% 396
2024
Q2
$78.9K Sell
506
-37
-7% -$5.57K ﹤0.01% 372
2024
Q1
$73.6K Hold
543
0.01% 361
2023
Q4
$73.1K Buy
+543
New +$70.6K 0.01% 343
2023
Q2
Sell
-43
Closed -$5.9K 1115
2023
Q1
$5.9K Sell
43
-65
-60% -$8.74K ﹤0.01% 675
2022
Q4
$14.6K Buy
108
+65
+151% +$8.15K ﹤0.01% 447
2022
Q3
$5K Buy
43
+38
+760% +$4.82K ﹤0.01% 577
2022
Q2
$1K Hold
5
﹤0.01% 775
2022
Q1
$1K Buy
+5
New +$600 ﹤0.01% 768
2021
Q1
Sell
-59
Closed -$6K 973
2020
Q4
$6K Hold
59
﹤0.01% 544
2020
Q3
$6K Hold
59
﹤0.01% 503
2020
Q2
$6K Hold
59
﹤0.01% 469
2020
Q1
$5K Hold
59
﹤0.01% 442
2019
Q4
$6K Hold
59
﹤0.01% 418
2019
Q3
$5K Buy
+59
New +$5.12K ﹤0.01% 410
2019
Q2
Sell
-22
Closed -$2K 665
2019
Q1
$2K Buy
+22
New +$1.73K ﹤0.01% 536
2018
Q3
Sell
-255
Closed -$18K 693
2018
Q2
$18K Buy
+255
New +$18.3K 0.01% 224

Other funds holding AZN

Sound Income Strategies's AZN Position: Q2 2026 in Review

Sound Income Strategies sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 788 shares — an estimated $158K sold.

Sound Income Strategies first reported a position in AZN in Q2 2018 and held it in 23 quarters. The position peaked at $158K in Q1 2026. 1,087 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Sound Income Strategies reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 788 AstraZeneca shares in Q2 2026, an estimated $158K.
  • Sound Income Strategies first reported a position in AstraZeneca in Q2 2018 and held it in 23 quarters.
  • Sound Income Strategies's AstraZeneca position peaked at $158K in Q1 2026.
  • 1,087 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.